IMAX China Holding, Inc.
IMAX China Holding, Inc. (IMXCF) Financial Performance & Income Statement Overview
Review IMAX China Holding, Inc. (IMXCF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
IMAX China Holding, Inc. (IMXCF) Income Statement & Financial Overview
Review IMAX China Holding, Inc. IMXCF income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $37.10M | $43.90M | $20.82M | $20.82M |
| Cost of Revenue | $18.18M | $18.80M | $7.91M | $7.91M |
| Gross Profit | $18.91M | $25.10M | $12.91M | $12.91M |
| Gross Profit Ratio | $0.51 | $0.57 | $0.62 | $0.62 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | -$4.28M | $7.22M | $4.77M | $4.77M |
| Operating Expenses | $6.98M | $9.51M | $5.008M | $5.008M |
| Total Costs & Expenses | $25.16M | $28.31M | $12.92M | $12.92M |
| Interest Income | $1.04M | $857000.00 | $1.13M | $501000.00 |
| Interest Expense | $68000.00 | $0.00 | $130142.00 | $0.00 |
| Depreciation & Amortization | $12.12M | $6.84M | $3.35M | $3.56M |
| EBITDA | $25.95M | $22.43M | $11.16M | $11.16M |
| EBITDA Ratio | $0.70 | $0.51 | $0.54 | $0.54 |
| Operating Income | $11.93M | $15.59M | $7.90M | $7.81M |
| Operating Income Ratio | $0.32 | $0.36 | $0.38 | $0.37 |
| Other Income/Expenses (Net) | $973000.00 | $857000.00 | $501000.00 | $594500.00 |
| Income Before Tax | $12.90M | $16.45M | $8.40M | $8.40M |
| Income Before Tax Ratio | $0.35 | $0.37 | $0.40 | $0.40 |
| Income Tax Expense | $3.34M | $3.80M | $1.59M | $1.59M |
| Net Income | $9.57M | $12.65M | $6.81M | $6.81M |
| Net Income Ratio | $0.26 | $0.29 | $0.33 | $0.33 |
| EPS | $0.03 | $0.04 | $0.02 | $0.02 |
| Diluted EPS | $0.03 | $0.04 | $0.02 | $0.02 |
| Weighted Avg Shares Outstanding | $340.002M | $340.10M | $340.63M | $340.63M |
| Weighted Avg Shares Outstanding (Diluted) | $342.31M | $342.19M | $342.44M | $342.44M |
Financial performance has remained strong, with revenue growing from $20.82M in Q3 2023 to $37.10M in Q4 2024. Gross profit continued to perform well, with margins at 51% in the latest quarter. Operating income reached $11.93M in Q4 2024, holding a steady 32% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $25.95M. Net income dropped to $9.57M, keeping EPS at $0.03. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan